» » New fusion protein, useful for selective treatment of monocytic leukemia, comprises a lipopolysaccharide-binding protein and a cell-damaging domain, cytotoxic or immune-response promoting domain
Информация к новости
  • Просмотров: 2852
  • Автор: admin
  • Дата: 20-01-2014, 21:28
20-01-2014, 21:28

New fusion protein, useful for selective treatment of monocytic leukemia, comprises a lipopolysaccharide-binding protein and a cell-damaging domain, cytotoxic or immune-response promoting domain

Category: Patents

DE10161739 (A1)
New fusion protein, useful for selective treatment of monocytic leukemia, comprises a lipopolysaccharide-binding protein and a cell-damaging domain, cytotoxic or immune-response promoting domain

DE10161739 (A1)
Back Комментариев: 0

Our Webseite Recommends:

Распечатать